EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SHC4 suppresses ferroptosis and promotes sorafenib resistance in hepatocellular carcinoma by disrupting the interaction between NCOA4 and FTH1

Dongqi Chai, Jiacheng Zhang, Keshuai Dong, Jia Yu, Xin Zhang, Tianrui Kuang, Jiarui Feng, Man Li, Weixing Wang

Cellular Signalling · 2026-10 · 146 · 112699

DOI: 10.1016/j.cellsig.2026.112699 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Signalling, 2026-10. Verfasst von Dongqi Chai und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei Province 40060, People's Republic of China; Central Laboratory…. Hauptthemen laut MEDLINE: Sorafenib, Ferroptosis, Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hubei Province Natural Science Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SorafenibFerroptosisCarcinoma, HepatocellularLiver NeoplasmsDrug Resistance, NeoplasmNuclear Receptor CoactivatorsFerritinsHumansAnimalsCell Line, TumorMiceMice, NudeSrc Homology 2 Domain-Containing, Transforming Protein 1Mice, Inbred BALB COxidoreductases

Stichwörter der Autor:innen

ErastinFTH1FerroptosisHepatocellular carcinomaNCOA4SHC4Sorafenib

Substanzen

SorafenibNCOA4 protein, humanNuclear Receptor CoactivatorsFTH1 protein, humanFerritinsSrc Homology 2 Domain-Containing, Transforming Protein 1Oxidoreductases

Autor:innen und Institutionen

  • Department of Hepatobiliary Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei Province 40060, People's Republic of China; Central Laboratory, Renmin Hospital of Wuhan University, Wuhan, Hubei Province 40060, Pe…
  • Department of Hepatobiliary Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei Province 40060, People's Republic of China; Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sic…
  • Department of Hepatobiliary Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei Province 40060, People's Republic of China.
  • Department of Hepatobiliary Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei Province 40060, People's Republic of China. Electronic address: liman192@whu.edu.cn.
  • Department of Hepatobiliary Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei Province 40060, People's Republic of China. Electronic address: wangwx@whu.edu.cn.

Förderung

  • Hubei Province Natural Science Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Chai, D., Zhang, J., Dong, K., Yu, J., Zhang, X., Kuang, T., Feng, J., Li, M., & Wang, W. (2026). SHC4 suppresses ferroptosis and promotes sorafenib resistance in hepatocellular carcinoma by disrupting the interaction between NCOA4 and FTH1. Cellular Signalling, 146, 112699. https://doi.org/10.1016/j.cellsig.2026.112699

Vancouver

Chai D, Zhang J, Dong K, Yu J, Zhang X, Kuang T, et al. SHC4 suppresses ferroptosis and promotes sorafenib resistance in hepatocellular carcinoma by disrupting the interaction between NCOA4 and FTH1. Cellular Signalling. 2026;146:112699. doi:10.1016/j.cellsig.2026.112699

BibTeX
@article{Chai2026,
  author = {Chai, Dongqi and Zhang, Jiacheng and Dong, Keshuai and Yu, Jia and Zhang, Xin and Kuang, Tianrui and Feng, Jiarui and Li, Man and Wang, Weixing},
  title = {SHC4 suppresses ferroptosis and promotes sorafenib resistance in hepatocellular carcinoma by disrupting the interaction between NCOA4 and FTH1},
  journal = {Cellular Signalling},
  year = {2026},
  volume = {146},
  pages = {112699},
  doi = {10.1016/j.cellsig.2026.112699}
}
Kostenlos starten →